Delivery Order SPE2DB24D1205-SPE2DB25FDAJT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,976.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1.5 milliliter syringes containing Leqvio 284 mg. The contract, which is not set-aside, was awarded on September 2, 2025, with a completion date of September 23, 2025. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This delivery order, valued at $4,651.10, awards AmerisourceBergen Drug Corp the supply of Leqvio 284 mg/1.5 mL syringes under a firm fixed-price contract with the Defense Logistics Agency (DLA). The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025, and represents a non-competitive delivery order against an existing contract vehicle. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the procurement of Leqvio 284 mg/1.5 ml syringes. The Firm Fixed Price contract, valued at $21,974.10, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- This is a $2,197.41 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Leqvio, a 284 mg/1.5 ml syringe pharmaceutical product, with a completion date of July 11, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,894 units of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $13,184.46 delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp has a longstanding relationship with DLA Troop Support Medical as a prime contractor providing pharmaceuticals, medical...
- The Defense Logistics Agency awarded a $23,255.50 delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on August 18, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's location in Conshohocken, Pennsylvania. LEQVIO is an injectable cardiovascular medication used to lower LDL cholesterol levels, reflecting the Defense...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Leqvio, a 284 mg/1.5 mL syringe medication, with a ceiling value of $4,651.10 and a period of performance through July 24, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp, as the prime contractor, will be responsible for providing the Leqvio medication...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAJTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,302.20 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order is scheduled for completion by October 2, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of drug deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Leqvio (inclisiran), a PCSK9 inhibitor used for cholesterol management, aligns with the company's comprehensive pharmaceutical supply capabilities across multiple therapeutic domains. This delivery order reflects AmerisourceBergen's ongoing role as a primary supplier within DLA's pharmaceutical distribution network supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/11/25 |